US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

36.30

+0.51001.42%

Post-market: 36.300.00000.00%16:00 EDT

Volume:17.74K

Turnover:641.47K

Market Cap:98.74M

PE:- -

High:36.45

Open:35.93

Low:35.75

Close:35.79

52wk High:36.84

52wk Low:23.42

Shares:2.72M

Float Shares:2.72M

Volume Ratio:0.58

T/O Rate:0.65%

Dividend:0.26

Dividend Rate:0.71%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

OCUMENSION-B's Dry Eye Candidate OT-202 Commences Late-Stage Dosing in China

Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients

MT Newswires Live

Amgen Repatha reduces risk of death in high-risk adults for first heart attack

Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke

THOMSON REUTERS

Fed's Hawkish Signal Hits Hong Kong Drug Stocks: Innovative Medicine ETFs Slide Sharply

Healthcare Sector Sees Continued Positive Signals; CCB Fund Manager Liang Furui Highlights High-Prosperity Areas Such as Innovative Drugs

New Listing Update | Betta Pharma Re-files for Hong Kong IPO, Leveraging a Quad-Driven Model to Build a Fully Integrated Biopharmaceutical Platform

ABBISKO-B Initiates First Patient Dosing in Phase I Trial for Novel Pan-KRAS Inhibitor

Three New Share Subscriptions Next Week Spanning AI Chip and Innovative Drug Hotspots; Nine IPOs This Year Have Already Delivered Over 100,000 Yuan Profit Per Lot

Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run

Simply Wall St.

Bai Hua Pharma's Surge Halts After Doubling Within a Month, Company Clarifies Innovation Drug CRO Remains Minimal

Crinetics Shareholders Approve Vertex Acquisition at Special Meeting

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo

Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors

Amgen’s Pediatric Psoriasis Study Wrap-Up: What Apremilast Safety Data Means for Investors

Domestic Innovative Drug Sector Shifts From Cash Burn to Profit Generation as Mid-Year Reports Roll In

Political and General News Events from August 28

Gilead Breaks Ground on Foster City Biologics Facility in $32 Billion US Investment Push

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/IBBQ/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":36.3,"timestamp":1788379200000,"preClose":35.79,"halted":0,"volume":17743,"hourTrading":{"tag":"盘后","latestPrice":36.3,"preClose":36.3,"latestTime":"16:00 EDT","volume":28,"amount":1016.3999999999999,"timestamp":1788379210532,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.014249790444258118,"floatShares":2720001,"shares":2720001,"eps":0,"marketStatus":"Post-Mkt","change":0.51,"latestTime":"09-02 16:03:16 EDT","open":35.93,"high":36.45,"low":35.7472,"amount":641470,"amplitude":0.019637,"askPrice":36.73,"askSize":8200,"bidPrice":35.86,"bidSize":8400,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788393600000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":35.79,"sharesOutstanding":2520001,"nav":35.43802,"aum":96391449.83802,"dividendRate":0.007052,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":35.79,"preClose":35.79,"latestTime":"07:00 EDT","volume":100,"amount":3579.2799999999997,"timestamp":1788346812804,"change":0,"changeRate":0,"amplitude":0.007823},"postHourTrading":{"tag":"盘后","latestPrice":36.3,"preClose":36.3,"latestTime":"16:00 EDT","volume":28,"amount":1016.3999999999999,"timestamp":1788379210532,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.580527,"impliedVol":0.1027,"impliedVolPercentile":0.4246},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":2720001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.580527,"shares":2720001,"dividePrice":0.256,"high":36.45,"amplitude":0.019637,"preClose":35.79,"low":35.7472,"week52Low":23.42,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":36.3,"committee":0.012048,"eps":0,"divideRate":0.007052,"volume":17743,"delay":0,"ttmEps":0,"open":35.93,"prevYearClose":28.3962,"prevWeekClose":35.47,"prevMonthClose":35.4742,"prevQuarterClose":32.66,"fiveDayClose":36.57,"twentyDayClose":32.93,"sixtyDayClose":28.77},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"IBBQ","amount":0.0287,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1131581918","title":"OCUMENSION-B's Dry Eye Candidate OT-202 Commences Late-Stage Dosing in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1131581918","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131581918?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:28","pubTimestamp":1788172096,"startTime":"0","endTime":"0","summary":"OCUMENSION-B (01477) has announced that the first patient has been enrolled in the Chinese Phase III clinical trial for OT-202, its investigational therapy for dry eye disease (DED). This milestone...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBJ","BK1191","IBBQ","BMED","PSYK","MDTX","BK1574","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663071381","title":"Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2663071381","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663071381?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:51","pubTimestamp":1788169915,"startTime":"0","endTime":"0","summary":"Amgen  said Monday that its cholesterol-lowering drug Repatha reduced the risk of death by 20% in high-risk adults without a prior heart attack or stroke.The findings came from a pre-specified analysis of the phase 3 VESALIUS-CV trial involving more than 12,000 patients and were presented at the European Society of Cardiology Congress 2026 in Munich, it said.Amgen said Repatha reduced both overall and cardiovascular deaths when added to statins or other LDL-C-lowering treatments. The mortality benefit emerged after about 1.5 years and continued through a median follow-up of 4.6 years, it added.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0289739699.SGD","IBB","LU2468319806.SGD","BK4599","LU2089984988.USD","LU2242646821.SGD","LU0320765992.SGD","BK4581","LU1057294990.SGD","IE00BJJMRZ35.SGD","BK4566","PJP","LU0058720904.USD","BK4534","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0868494617.USD","LU2112291526.USD","IE00BJT1NW94.SGD","IE0002141913.USD","BIB","IBBQ","LU1983299246.USD","AMGN","LU2242652126.USD","LU1571399168.USD","SG9999001440.SGD","LU1023059063.AUD","TBXU","IE0009355771.USD","LU0122379950.USD","LU1061106388.HKD","PBE","LU0889565916.HKD","LU0109394709.USD","BK4139","BK4585","BBH","BK4533","IE00BFTCPJ56.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663249076","title":"Amgen Repatha reduces risk of death in high-risk adults for first heart attack","url":"https://stock-news.laohu8.com/highlight/detail?id=2663249076","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663249076?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:10","pubTimestamp":1788167413,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) announced new findings showing Repatha reduced the risk of death in high-risk adults without a prior heart attack or stroke when added...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-repatha-reduces-risk-of-death-in-high-risk-adults-for-first-heart-attack-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-repatha-reduces-risk-of-death-in-high-risk-adults-for-first-heart-attack-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","IE00BFTCPJ56.SGD","BBH","LU0109394709.USD","PJP","BK4599","LU1023059063.AUD","BK4588","LU1061106388.HKD","LU2468319806.SGD","TBXU","LU2112291526.USD","BIB","IBBQ","BK4585","IE00BJT1NW94.SGD","IE0002141913.USD","BK4534","LU0889565916.HKD","IBB","LU1983299246.USD","LU2242652126.USD","LU0289739699.SGD","IE00B2B36J28.USD","LU0058720904.USD","LU1057294990.SGD","LU2242646821.SGD","BK4566","BK4533","LU0320765992.SGD","BK4139","LU0868494617.USD","LU1571399168.USD","SG9999001440.SGD","PBE","IE00B4R5TH58.HKD","AMGN","LU0122379950.USD","BK4581","LU2089984988.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663202044","title":"Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke","url":"https://stock-news.laohu8.com/highlight/detail?id=2663202044","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663202044?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:18","pubTimestamp":1788160736,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUA6XK0BH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4566","LU0058720904.USD","LU2112291526.USD","LU2468319806.SGD","LU1061106388.HKD","PJP","BK4139","BK4588","LU1057294990.SGD","LU1983299246.USD","SG9999001440.SGD","BBH","BK4534","AMGN","LU0320765992.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU2242652126.USD","LU0889565916.HKD","LU0868494617.USD","BK4581","IBBQ","LU0122379950.USD","IE0009355771.USD","LU2242646821.SGD","BK4533","PBE","IE00BJJMRZ35.SGD","BK4585","LU2089984988.USD","IE0002141913.USD","TBXU","LU1571399168.USD","LU1023059063.AUD","IE00B2B36J28.USD","IBB","BK4599","BIB","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194450851","title":"Fed's Hawkish Signal Hits Hong Kong Drug Stocks: Innovative Medicine ETFs Slide Sharply","url":"https://stock-news.laohu8.com/highlight/detail?id=1194450851","media":"Deep News","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194450851?lang=en_us&edition=fundamental","pubTime":"2026-08-31 11:26","pubTimestamp":1788146800,"startTime":"0","endTime":"0","summary":"On the final trading day of August, Hong Kong equities faced broad declines with the Hang Seng Index and Hang Seng Tech Index both dipping over 1% intraday, while the innovative drug industry chain...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMF","XLF","KRE","VCIT","ZROZ","FEM","US10Y.BOND","BK4588","US30Y.BOND","SCHO","WAMA","BBIB","EBUF","TFJL","TBIL","06978","YSPY","159828","VGIT","IEF","IGOV","NEMD","PBDC","VEXC","BK4534","JULD","RAUS","SHV","HYG","SHY","BOXX","HMOP","SKRE","GBIL","HYGD","SPDN","TBT","KBWB","VCSH","LQDU","ZTmain","BK4535","BK4561","SH","MESmain","ISHG","TIP","XBIL","CIVG","AGG","BK4559","IVV","NGHT","SMAX","SPXL","OEX","US7Y.BOND","SPXU","MEDX","TBJL","TLTI","US2Y.BOND","GOVT","BK4550","VFH","159137","FAZ","UBmain","UDN",".SPX","SPUU","BSV","BBLB","IBBQ","SGOV","OOQB","TLH","MINT","MUNX","UBT","US12M.BOND","XLRI","ZFmain","UPRO","SPY","MYCN","BK1161","BWZ","US3Y.BOND","LNGR","SPYI","BK4581","MMAX","OEF","US6M.BOND","LIAJ","520880","SPYB","IEI","TLT","BIL","SSO","BND","HIBL","EDV","MUB","BK4504","ESmain","FLGV","KBE","BBSB","HK0000934320.USD","BK1574","SDS","BOND","DPST","VGLT","KRX","LQD","HYGU","159992","ZBmain","TLTW","TLTX","TNmain","JPST","VOO","SPXS","BWX","SPYM","BK4585","VGSH","IAT","LQDD","US5Y.BOND","NELS","UUP","DBND","GOLY","TSYW","EMPB","SPYU","USHY","SPYQ","159316","SPYH","TYO","FLHK","DMAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170146874","title":"Healthcare Sector Sees Continued Positive Signals; CCB Fund Manager Liang Furui Highlights High-Prosperity Areas Such as Innovative Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=1170146874","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170146874?lang=en_us&edition=fundamental","pubTime":"2026-08-31 09:31","pubTimestamp":1788139881,"startTime":"0","endTime":"0","summary":"A wave of encouraging signals has recently emerged across the healthcare industry. The National Healthcare Security Administration and the National Medical Products Administration have coordinated...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","MEDX","BK1161","IBBQ","BK1574","LNGR","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148310736","title":"New Listing Update | Betta Pharma Re-files for Hong Kong IPO, Leveraging a Quad-Driven Model to Build a Fully Integrated Biopharmaceutical Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=1148310736","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148310736?lang=en_us&edition=fundamental","pubTime":"2026-08-31 08:30","pubTimestamp":1788136244,"startTime":"0","endTime":"0","summary":"Based on the Hong Kong Stock Exchange disclosure on August 28, Betta Pharmaceuticals Co., Ltd. (300558.SZ) has submitted a listing application for the Main Board, with CITIC Securities acting as its...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNY","BK0239","IPOS","BBP","03069","HEXmain","IBBQ","300558","BK0060","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185737367","title":"ABBISKO-B Initiates First Patient Dosing in Phase I Trial for Novel Pan-KRAS Inhibitor","url":"https://stock-news.laohu8.com/highlight/detail?id=1185737367","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185737367?lang=en_us&edition=fundamental","pubTime":"2026-08-31 08:22","pubTimestamp":1788135744,"startTime":"0","endTime":"0","summary":"ABBISKO-B has announced that its subsidiary, Shanghai Abbisko Biopharmaceutical Co., Ltd., has completed the first patient dosing in a Phase I clinical trial for ABSK211, an oral, high-potency,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","BK1161","LU2488822045.USD","PSYK","LU2778985437.USD","IE00B543WZ88.USD","LU2476274720.SGD","IE00B5MMRT66.SGD","LU2476274308.USD","IE00BPRC5H50.USD","02256","MDTX","BMED","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120832388","title":"Three New Share Subscriptions Next Week Spanning AI Chip and Innovative Drug Hotspots; Nine IPOs This Year Have Already Delivered Over 100,000 Yuan Profit Per Lot","url":"https://stock-news.laohu8.com/highlight/detail?id=1120832388","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120832388?lang=en_us&edition=fundamental","pubTime":"2026-08-30 14:30","pubTimestamp":1788071447,"startTime":"0","endTime":"0","summary":"The new share market has remained active this week. On Tuesday (August 25), Gaoke Technology made its debut on the STAR Market with an issue price of 61.36 yuan per share. The stock peaked at 262...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","AVGG","03191","WISE","AIS","AIVC","BK1574","AVGX","ALAI","AVGW","159992","AVS","LNGR","MEDX","AVGC","FAI","EPAI","GPTZ","AIFD","06978","IBBQ","AVL","AVGU","LRNZ","AIBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663043488","title":"Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2663043488","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663043488?lang=en_us&edition=fundamental","pubTime":"2026-08-30 07:30","pubTimestamp":1788046226,"startTime":"0","endTime":"0","summary":"Gilead Sciences stock has delivered very strong gains over the past few years, yet current valuation checks still suggest the shares screen as inexpensive on several metrics. The question for investors is how that strong track record and the latest product approvals align with a profile that continues to lean cheap.\n\nOver 5 years the stock has returned about 143%, which puts recent moves in the context of a long, powerful run that investors now need to judge against today’s pricing.\nThe...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-stays-cheap-after-a-143-five-year-run","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-stays-cheap-after-a-143-five-year-run","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4566","LU0114720955.EUR","LU1066051498.USD","LU1934455863.HKD","BK4578","BK4568","LU2468319806.SGD","BMED","LU0965508806.USD","MEDI","IE00B3T34201.USD","LU0234570918.USD","TBXU","IE00BZ1G4Q59.USD","LU0965509010.AUD","LU1023059063.AUD","LU1839511570.USD","LU1934455277.USD","LU2324357040.USD","BBH","BK4585","SG9999015945.SGD","IBB","GILD","LU0109394709.USD","LU0882574055.USD","LU1066053197.SGD","LU0823416689.USD","IE00BKVL7J92.USD","BK4583","IE00B19Z3B42.SGD","LU0965509283.SGD","LU1061106388.HKD","BIB","LU2112291526.USD","LU0122379950.USD","BK4532","LU1430594728.SGD","IBBQ","BK4550","TMED","BK4139","BK4588","SG9999015978.USD","LU1934455194.USD","LU1585245621.USD","LU1571399168.USD","LU0058720904.USD","LU2089984988.USD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137049499","title":"Bai Hua Pharma's Surge Halts After Doubling Within a Month, Company Clarifies Innovation Drug CRO Remains Minimal","url":"https://stock-news.laohu8.com/highlight/detail?id=1137049499","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137049499?lang=en_us&edition=fundamental","pubTime":"2026-08-29 13:50","pubTimestamp":1787982621,"startTime":"0","endTime":"0","summary":"On August 28, Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd. hit the daily limit down during intraday trading. Wind data shows that by the close of trading on August 28, the company's shares settled at...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0216","BK0102","06978","BK1161","MEDX","IBBQ","600721","LNGR","159992","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663015099","title":"Crinetics Shareholders Approve Vertex Acquisition at Special Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2663015099","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663015099?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:33","pubTimestamp":1787952818,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals ( ($CRNX) ) has provided an update. On August 28, 2026, Crinetics Pharmaceuticals shareholders held a special meeting at ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/crinetics-shareholders-approve-vertex-acquisition-at-special-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/crinetics-shareholders-approve-vertex-acquisition-at-special-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999001176.SGD","LU2468319806.SGD","BK4532","IBBQ","BIB","LU2417539215.USD","IE0009355771.USD","IE0002141913.USD","LU1674673691.USD","BBH","LU1778281490.HKD","IE00B894F039.SGD","LU0061475181.USD","IE00B19Z3B42.SGD","LU0320765992.SGD","BK4585","BK4567","LU0079474960.USD","LU1069344957.HKD","LU2462157665.USD","IDNA","LU0432979614.USD","LU2236285917.USD","IE00BJJMRZ35.SGD","LU2324357040.USD","TBXU","LU0256863811.USD","LU1815336091.USD","LU2362540622.SGD","LU1093756168.USD","LU1674673428.USD","BK4023","LU0289739699.SGD","IE00BZ9MQY76.HKD","IE00B19Z9P08.USD","LU1430594728.SGD","IE00BFTCPJ56.SGD","GNMX","LU0823416689.USD","BK4588","LU0234570918.USD","PBE","LU0757428866.USD","IBB","VERX","BK4533","IE00BJT1NW94.SGD","VRTX","IE00B19Z3581.USD","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663701587","title":"Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663701587","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663701587?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:35","pubTimestamp":1787949300,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slid 2.14% to $145.68 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,711.76 and Dow Jones Industrial Average  falling 0.02% to 53,559.99.Gilead Sciences Inc. closed 7.38% short of its 52-week high of $157.29, which the company achieved on February 11th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  rose 0.85% to $268.04, Pfizer Inc.  fell 0.21% to $27.96, and Abbott Laboratories  rose 0.79% to $112.47.Trading volume  remained 3.2 million below its 50-day average volume of 7.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","LU1061106388.HKD","MEDI","BMED","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","IE0002270589.USD","LU0320765992.SGD","LU1057294990.SGD","LU0114720955.EUR","LU2324357040.USD","IE00B7SZLL34.SGD","LU0965508806.USD","LU1037948897.HKD","LU0859254822.USD","BK4139","LU0058720904.USD","LU1674673691.USD","LU1778281490.HKD","LU2089984988.USD","LU0965509010.AUD","LU2112291526.USD","LU1066051498.USD","BK4585","LU2357627491.SGD","LU1839511570.USD","TMED","BK4578","BK4550","LU2468319806.SGD","LU0823416689.USD","SG9999015986.USD","BK4532","SG9999015952.SGD","BBH","LU2087621335.USD","BK4588","LU1430594728.SGD","LU1585245621.USD","LU0889565916.HKD","LU0289739699.SGD","SG9999015978.USD","TBXU","SG9999015945.SGD","IBBQ","LU1023059063.AUD","LU0861579265.USD","LU1066053197.SGD","LU0965509101.SGD","BK4568","BK4566","LU1037948541.HKD","LU0882574055.USD","IE00B19Z3581.USD","LU0965509283.SGD","LU1674673428.USD","LU1934455277.USD","LU1934455863.HKD","LU0234570918.USD","GILD","BIB","IE00B19Z3B42.SGD","LU1934455194.USD","LU0122379950.USD","LU0109394709.USD","LU1571399168.USD","IE00B3T34201.USD","BK4583","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663015807","title":"Amgen Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663015807","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663015807?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:34","pubTimestamp":1787949240,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  slipped 1.05% to $432.42 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,711.76 and Dow Jones Industrial Average  falling 0.02% to 53,559.99.This was the stock's fourth consecutive day of losses.Amgen Inc. closed 3.27% below its 52-week high of $447.03, which the company reached on August 25th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  rose 0.85% to $268.04, Pfizer Inc.  fell 0.21% to $27.96, and AbbVie Inc.  fell 1.03% to $255.48.Trading volume  remained 889,592 below its 50-day average volume of 2.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4585","LU0109394709.USD","LU1061106388.HKD","LU0889565916.HKD","LU1571399168.USD","BK4581","LU0320765992.SGD","LU2112291526.USD","IE00B2B36J28.USD","BK4534","IE00BJT1NW94.SGD","IBB","LU0122379950.USD","BK4533","PJP","LU0058720904.USD","LU2089984988.USD","BK4566","BBH","LU0868494617.USD","LU1023059063.AUD","TBXU","SG9999001440.SGD","IE0002141913.USD","LU1983299246.USD","BIB","BK4588","LU2242646821.SGD","IE00BJJMRZ35.SGD","LU2468319806.SGD","PBE","LU1057294990.SGD","IBBQ","LU2242652126.USD","04332","LU0289739699.SGD","IE0009355771.USD","BK4599","AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663018885","title":"Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo","url":"https://stock-news.laohu8.com/highlight/detail?id=2663018885","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663018885?lang=en_us&edition=fundamental","pubTime":"2026-08-29 01:20","pubTimestamp":1787937637,"startTime":"0","endTime":"0","summary":"Gilead Sciences stock was down roughly 2% on Friday alongside an FDA update concerning HIV drug Bixlenvo.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/gilead-sciences-stock-gild-slips-2-despite-fda-approval-of-bixlenvo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/gilead-sciences-stock-gild-slips-2-despite-fda-approval-of-bixlenvo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0859254822.USD","MEDI","LU0114720955.EUR","TBXU","LU1057294990.SGD","LU1066053197.SGD","BIB","SG9999015986.USD","LABU","IBBQ","LU0965509010.AUD","LU1934455863.HKD","BK4578","LU0109394709.USD","SG9999015978.USD","LU0823416689.USD","LU0882574055.USD","IE00B19Z3B42.SGD","GILD","LU0965509101.SGD","BMED","BK4585","TMED","LU1066051498.USD","BK4532","BK4588","IE00B19Z3581.USD","BK4566","LU1934455194.USD","LU1778281490.HKD","LU1674673691.USD","BBH","LU1037948897.HKD","IE00BSNM7G36.USD","LU0320765992.SGD","IE00B7SZLL34.SGD","BK4139","SG9999015945.SGD","LU1934455277.USD","LU1571399168.USD","IBB","LU0889565916.HKD","LU2357627491.SGD","LU1037948541.HKD","IE00B3T34201.USD","LU0122379950.USD","IE0002270589.USD","LU2112291526.USD","LU1585245621.USD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663097210","title":"Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663097210","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663097210?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:30","pubTimestamp":1787934634,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals Inc. ($VRTX) announced an update on their ongoing clinical study. Vertex’s new Phase 1 study, officially titled “A Phase 1, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-tests-vx-407s-impact-on-birth-control-what-it-means-for-vrtx-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-tests-vx-407s-impact-on-birth-control-what-it-means-for-vrtx-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VRTX","LU1815336091.USD","IBBQ","BK4211","SG9999013999.USD","LU0889565916.HKD","LU0417517546.SGD","IE0009355771.USD","LU1585245621.USD","IE00B19Z3581.USD","LU2417539215.USD","LU1559883803.SGD","BK4585","BK4588","LU0823416689.USD","LU2362540622.SGD","BIB","IE0002270589.USD","TBXU","SGXZ57979304.SGD","LU2362541273.HKD","SG9999001176.USD","LU2362541513.USD","BK4139","IE00B19Z9Z06.USD","IE00BJT1NW94.SGD","BK4023","LU1674673428.USD","IE00B894F039.SGD","IE00BZ9MQY76.HKD","LU2089984988.USD","LU0566484027.USD","LU2324357040.USD","ISBC","LU2468319806.SGD","VERX","LU0320765992.SGD","BBH","IBB","IE00B2B36J28.USD","LU1093756325.SGD","PBE","BK4567","GNMX","IDNA","LU2237438978.USD","LU0058720904.USD","SG9999001176.SGD","LU1430594728.SGD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663225097","title":"Amgen’s Pediatric Psoriasis Study Wrap-Up: What Apremilast Safety Data Means for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663225097","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663225097?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:30","pubTimestamp":1787934627,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen’s latest psoriasis study update spotlights apremilast (AMG 407) for ki...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-pediatric-psoriasis-study-wrap-up-what-apremilast-safety-data-means-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-pediatric-psoriasis-study-wrap-up-what-apremilast-safety-data-means-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B2B36J28.USD","LU2089984988.USD","LU0868494617.USD","LU2468319806.SGD","TBXU","BK4139","LU0289739699.SGD","BIB","BK4211","LU0109394709.USD","IE0009355771.USD","BK4585","LU2242652126.USD","BK4533","SG9999001440.SGD","BK4588","AMGN","IBBQ","IE00BFTCPJ56.SGD","BBH","IE00BJJMRZ35.SGD","BK4566","IE00B4R5TH58.HKD","LU0058720904.USD","LU0889565916.HKD","BK4581","LU1983299246.USD","PJP","IE00BJT1NW94.SGD","LU2112291526.USD","PBE","IBB","LU0320765992.SGD","LU1061106388.HKD","LU1023059063.AUD","LU1571399168.USD","LU0122379950.USD","IE0002141913.USD","BK4534","ISBC","LU1057294990.SGD","BK4599","LU2242646821.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126390441","title":"Domestic Innovative Drug Sector Shifts From Cash Burn to Profit Generation as Mid-Year Reports Roll In","url":"https://stock-news.laohu8.com/highlight/detail?id=1126390441","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126390441?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:30","pubTimestamp":1787920254,"startTime":"0","endTime":"0","summary":"As August draws to a close, the release of mid-year reports from innovative drug companies is accelerating, drawing heightened attention to the sector. How did domestic innovative drug developers...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","IBBQ","159992","MEDX","BK1574","BK1161","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662098405","title":"Political and General News Events from August 28","url":"https://stock-news.laohu8.com/highlight/detail?id=2662098405","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662098405?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:30","pubTimestamp":1787920229,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from August 28Aug 28 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/DI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL4N44P0YN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU2468319806.SGD","LU0058720904.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","IBBQ","LU2242652126.USD","BK4585","IE00BJJMRZ35.SGD","PJP","TBXU","IE00B4R5TH58.HKD","LU1057294990.SGD","LU0122379950.USD","IE0009355771.USD","BK4533","IE00BFTCPJ56.SGD","LU2112291526.USD","LU0868494617.USD","LU0320765992.SGD","BK4588","IE0002141913.USD","BK4566","LU1571399168.USD","BK4599","LU1023059063.AUD","LU2242646821.SGD","PBE","LU1061106388.HKD","LU0289739699.SGD","BK4534","IBB","LU0889565916.HKD","SG9999001440.SGD","AMGN","BIB","LU1983299246.USD","BK4139","LU2089984988.USD","BBH","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662762030","title":"Gilead Breaks Ground on Foster City Biologics Facility in $32 Billion US Investment Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2662762030","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662762030?lang=en_us&edition=fundamental","pubTime":"2026-08-28 10:17","pubTimestamp":1787883449,"startTime":"0","endTime":"0","summary":"Gilead breaks ground on Foster City biologics facility in $32 billion US investment pushGilead broke ground on its Chess biologics facility at its Foster City, California headquarters as part of a pla","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL98vB5b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1037948897.HKD","IE0002270589.USD","LU0859254822.USD","LU0965508806.USD","LU0965509101.SGD","BMED","GILD","IBB","IE00BKVL7J92.USD","IE00B7SZLL34.SGD","LU1674673428.USD","LU1066053197.SGD","BIB","LU0234570918.USD","SG9999015952.SGD","LU1061106388.HKD","LU0109394709.USD","IE00B19Z3581.USD","BK4578","LU1430594728.SGD","LU1066051498.USD","LU1037948541.HKD","BK4568","LU0289739699.SGD","BBH","LU0861579265.USD","IBBQ","LU2357627491.SGD","LU2468319806.SGD","LU0058720904.USD","BK4532","LU0320765992.SGD","LU0823416689.USD","LU0965509283.SGD","IE00BSNM7G36.USD","LU2324357040.USD","LU1571399168.USD","LU0889565916.HKD","BK4583","TBXU","LU1934455194.USD","LU1674673691.USD","TMED","LU1057294990.SGD","LU2087621335.USD","MEDI","LU0965509010.AUD","LU2112291526.USD","LU1934455863.HKD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}